Literature DB >> 21222036

Patterns of left ventricular remodeling in patients with Duchenne Muscular Dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain.

Wojciech Mazur1, Kan N Hor, Joshua T Germann, Robert J Fleck, Hussein R Al-Khalidi, Janaka P Wansapura, Eugene S Chung, Michael D Taylor, John L Jefferies, D Woodrow Benson, William M Gottliebson.   

Abstract

The cardiac disease ubiquitously associated in Duchenne Muscular Dystrophy (DMD) has traditionally been considered a progressive dilated cardiomyopathy (DCM). However, left ventricular (LV) dilatation as measured with cardiac MRI has not been a consistent finding in this population, even as circumferential strain (ε(cc)) declines with advancing disease. We hypothesized that a distinct pattern of changes in LV geometry, during the course of ε(cc) decline, distinguishes DMD associated heart disease from DCM. Using CMR, LV end-diastolic volume (EDV), mass (LVM), ejection fraction, ε(cc) and myocardial delayed enhancement (MDE) were determined in DMD patients and normal control subjects. The LV Remodeling Index (LVRI) was calculated as the ratio of LV Mass to Volume (LVM/EDV). Statistical comparisons between all LV parameters and genotype were also performed. Median LVRI in DMD (n = 127) and control subjects (n = 41) were different (0.75 vs. 0.65, P = 0.0150) but within normal range. Furthermore, the median LVRI in DMD boys with reduced LV systolic function was significantly reduced compared to those with normal LV systolic function (0.64 vs. 0.75, P = 0.0974). However, the presence of MDE was associated with a lower median LVRI (0.57 vs. 0.76, P = 0.0471). Regression analysis showed no significant correlation between ε(cc) and LVRI (r = -0.03). The LVRI of DMD patients is unexpectedly normal and not correlated with ε(cc.) Based on these findings, DMD-associated heart disease exhibits a unique remodeling pattern distinct from DCM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222036     DOI: 10.1007/s10554-010-9781-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  28 in total

1.  Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy.

Authors:  Sean C Hagenbuch; William M Gottliebson; Janaka Wansapura; Wojciech Mazur; Robert Fleck; D Woodrow Benson; Kan N Hor
Journal:  Am J Cardiol       Date:  2010-03-30       Impact factor: 2.778

2.  Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Biotechnology       Date:  1992

3.  The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis.

Authors:  K A Frankel; R J Rosser
Journal:  Hum Pathol       Date:  1976-07       Impact factor: 3.466

4.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

5.  Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.

Authors:  John L Jefferies; Benjamin W Eidem; John W Belmont; William J Craigen; Stephanie M Ware; Susan D Fernbach; Steven R Neish; E O'brian Smith; Jeffrey A Towbin
Journal:  Circulation       Date:  2005-10-24       Impact factor: 29.690

6.  Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy.

Authors:  P N Ray; B Belfall; C Duff; C Logan; V Kean; M W Thompson; J E Sylvester; J L Gorski; R D Schmickel; R G Worton
Journal:  Nature       Date:  1985 Dec 19-1986 Jan 1       Impact factor: 49.962

7.  Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.

Authors:  A Ganau; R B Devereux; M J Roman; G de Simone; T G Pickering; P S Saba; P Vargiu; I Simongini; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1992-06       Impact factor: 24.094

8.  Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.

Authors:  Kan N Hor; Janaka Wansapura; Larry W Markham; Wojciech Mazur; Linda H Cripe; Robert Fleck; D Woodrow Benson; William M Gottliebson
Journal:  J Am Coll Cardiol       Date:  2009-04-07       Impact factor: 24.094

9.  Normal biventricular function, volumes, and mass in children aged 8 to 17 years.

Authors:  Daniëlle Robbers-Visser; Eric Boersma; Willem A Helbing
Journal:  J Magn Reson Imaging       Date:  2009-03       Impact factor: 4.813

10.  An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy.

Authors:  S K Sanyal; W W Johnson; M K Thapar; S E Pitner
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

View more
  21 in total

1.  Connecting enterovirus infection to dystrophin dysfunction in dilated cardiomyopathy.

Authors:  Qiongling Wang; Xander H T Wehrens
Journal:  Ann Transl Med       Date:  2016-10

Review 2.  Cardiovascular imaging 2012 in the International Journal of Cardiovascular Imaging.

Authors:  Hiram G Bezerra; Ricardo A Costa; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2013-04       Impact factor: 2.357

3.  Comparison of left ventricular function assessment between echocardiography and MRI in Duchenne muscular dystrophy.

Authors:  Sujatha Buddhe; Mark Lewin; Aaron Olson; Mark Ferguson; Brian D Soriano
Journal:  Pediatr Radiol       Date:  2016-05-12

4.  Dystrophin genotype-cardiac phenotype correlations in Duchenne and Becker muscular dystrophies using cardiac magnetic resonance imaging.

Authors:  Animesh Tandon; John L Jefferies; Chet R Villa; Kan N Hor; Brenda L Wong; Stephanie M Ware; Zhiqian Gao; Jeffrey A Towbin; Wojciech Mazur; Robert J Fleck; Joshua J Sticka; D Woodrow Benson; Michael D Taylor
Journal:  Am J Cardiol       Date:  2015-01-15       Impact factor: 2.778

5.  Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 6.  Cardiac involvement in Duchenne and Becker muscular dystrophy.

Authors:  Sophie Mavrogeni; George Markousis-Mavrogenis; Antigoni Papavasiliou; Genovefa Kolovou
Journal:  World J Cardiol       Date:  2015-07-26

7.  Effect of free-breathing on left ventricular rotational mechanics in healthy subjects and patients with duchenne muscular dystrophy.

Authors:  Meral L Reyhan; Zhe Wang; Hyun J Kim; Nancy J Halnon; J Paul Finn; Daniel B Ennis
Journal:  Magn Reson Med       Date:  2016-02-17       Impact factor: 4.668

8.  Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging.

Authors:  Jonathan H Soslow; Bruce M Damon; Benjamin R Saville; Zengqi Lu; W Bryan Burnette; Mark A Lawson; David A Parra; Douglas B Sawyer; Larry W Markham
Journal:  Pediatr Cardiol       Date:  2014-07-29       Impact factor: 1.655

9.  Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model.

Authors:  Zachary M Howard; Lisa E Dorn; Jeovanna Lowe; Megan D Gertzen; Pierce Ciccone; Neha Rastogi; Guy L Odom; Federica Accornero; Jeffrey S Chamberlain; Jill A Rafael-Fortney
Journal:  JCI Insight       Date:  2021-04-08

Review 10.  [Current care strategies for Duchenne muscular dystrophy].

Authors:  A Fujak; G Haaker; J Funk
Journal:  Orthopade       Date:  2014-07       Impact factor: 1.004

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.